Carol Strong1, Hee-Soon Juon2, Margaret E Ensminger3. 1. a Department of Public Health , National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University , Tainan , Taiwan. 2. b Department of Medical Oncology , Thomas Jefferson University , Philadelphia , Pennsylvania , USA. 3. c Department of Health, Behavior, and Society , Johns Hopkins Bloomberg School of Public Health , Baltimore , Maryland , USA.
Abstract
BACKGROUND: Even though the association between cigarette smoking and later substance use has been shown, there is still no compelling evidence that demonstrates the long-term effects in a high drug using community in African Americans. Few studies have examined the mediating mechanisms of the effect of adolescent cigarette smoking on the drug progression pathway. OBJECTIVES: We examined the long-term influence of adolescent smoking on later illegal drug use in a cohort of urban African Americans, and the mediating role of educational attainment in the drug progression pathway. METHODS: The study used a longitudinal dataset from the Woodlawn Project that followed 1,242 African Americans from 1966-1967 (at age 6-7) through 2002-2003 (at age 42-43). We used the propensity score matching method to find a regular and a nonregular adolescent smoking group that had similar childhood characteristics; we used the matched sample to assess the association between adolescent smoking and drug progression, and the mediating role of educational attainment. RESULTS: Adolescent regular smokers showed significantly higher odds of using marijuana, cocaine, and heroin, having alcohol abuse problems and any drug dependence, and abuse problems in adulthood. We found that educational attainment mediated most of the drug progression pathway, including cigarette smoking, marijuana, cocaine and heroin use, and drug dependence or abuse problems in adulthood, but not alcohol abuse. CONCLUSIONS: More focus needs to be put on high school dropout and development of interventions in community settings for African Americans to alter the pathway for drug progression for adolescents who use cigarettes regularly.
BACKGROUND: Even though the association between cigarette smoking and later substance use has been shown, there is still no compelling evidence that demonstrates the long-term effects in a high drug using community in African Americans. Few studies have examined the mediating mechanisms of the effect of adolescent cigarette smoking on the drug progression pathway. OBJECTIVES: We examined the long-term influence of adolescent smoking on later illegal drug use in a cohort of urban African Americans, and the mediating role of educational attainment in the drug progression pathway. METHODS: The study used a longitudinal dataset from the Woodlawn Project that followed 1,242 African Americans from 1966-1967 (at age 6-7) through 2002-2003 (at age 42-43). We used the propensity score matching method to find a regular and a nonregular adolescent smoking group that had similar childhood characteristics; we used the matched sample to assess the association between adolescent smoking and drug progression, and the mediating role of educational attainment. RESULTS: Adolescent regular smokers showed significantly higher odds of using marijuana, cocaine, and heroin, having alcohol abuse problems and any drug dependence, and abuse problems in adulthood. We found that educational attainment mediated most of the drug progression pathway, including cigarette smoking, marijuana, cocaine and heroin use, and drug dependence or abuse problems in adulthood, but not alcohol abuse. CONCLUSIONS: More focus needs to be put on high school dropout and development of interventions in community settings for African Americans to alter the pathway for drug progression for adolescents who use cigarettes regularly.
Entities:
Keywords:
African Americans; cigarette smoking; drug progression; gateway theory; propensity score matching; substance use
Authors: Jorge Delva; Marisol Tellez; Tracy L Finlayson; Kimberlee A Gretebeck; Kristine Siefert; David R Williams; Amid I Ismail Journal: Am J Prev Med Date: 2005-10 Impact factor: 5.043
Authors: Frederika A van Nimwegen; John Penders; Ellen E Stobberingh; Dirkje S Postma; Gerard H Koppelman; Marjan Kerkhof; Naomi E Reijmerink; Edward Dompeling; Piet A van den Brandt; Isabel Ferreira; Monique Mommers; Carel Thijs Journal: J Allergy Clin Immunol Date: 2011-08-27 Impact factor: 10.793
Authors: Danice K Eaton; Laura Kann; Steve Kinchen; Shari Shanklin; James Ross; Joseph Hawkins; William A Harris; Richard Lowry; Tim McManus; David Chyen; Connie Lim; Nancy D Brener; Howell Wechsler Journal: MMWR Surveill Summ Date: 2008-06-06
Authors: Barri B Burrus; Kathleen Krieger; Regina Rutledge; Alexander Rabre; Sarah Axelson; Audra Miller; LeBretia White; Christine Jackson Journal: Am J Public Health Date: 2018-02 Impact factor: 9.308
Authors: Jibran Y Khokhar; Lucas L Dwiel; Angela M Henricks; Wilder T Doucette; Alan I Green Journal: Schizophr Res Date: 2017-04-14 Impact factor: 4.939
Authors: Natalia A Quijano Cardé; Jessica Shaw; Christina Carter; Seung Kim; Jerry A Stitzel; Shyamala K Venkatesh; Vijay A Ramchandani; Mariella De Biasi Journal: Neuropharmacology Date: 2022-06-22 Impact factor: 5.273
Authors: Allison N Kurti; Diana R Keith; Alyssa Noble; Jeff S Priest; Brian Sprague; Stephen T Higgins Journal: Prev Med Date: 2016-09-26 Impact factor: 4.018
Authors: Nerea Requena-Ocaña; María Flores-Lopez; Alicia San Martín; Nuria García-Marchena; María Pedraz; Juan Jesús Ruiz; Antonia Serrano; Juan Suarez; Francisco Javier Pavón; Fernando Rodríguez de Fonseca; Pedro Araos Journal: Sci Rep Date: 2021-10-22 Impact factor: 4.379